• norsk
    • English
  • norsk 
    • norsk
    • English
  • Logg inn
Blar i på forfatter 
  •   Hjem
  • Blar i på forfatter
  •   Hjem
  • Blar i på forfatter
JavaScript is disabled for your browser. Some features of this site may not work without it.

Blar i NTNU Open på forfatter "Robertsen, Ida"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Æ
  • Ø
  • Å

Sorter på:

Rekkefølge:

Resultater:

Viser treff 1-2 av 2

  • Tittel
  • Utgivelsesdato
  • Registreringsdato
  • Forfatter
  • stigende
  • synkende
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL) 

      Hjelmesæth, Jøran; Åsberg, Anders; Andersson, Shalini; Sandbu, Rune; Robertsen, Ida; Johnson, Line Kristin; Angeles, Philip Carlo Soriano; Hertel, Jens Kristoffer; Skovlund, Eva; Heijer, Maria; Ek, Anna-Lena; Krogstad, Veronica; Karlsen, Tor-Ivar; Christensen, Hege Staaland; Andersson, Tommy B; Karlsson, Cecilia (Journal article; Peer reviewed, 2018)
      Introduction: Roux-en-Y gastric bypass (GBP) is associated with changes in cardiometabolic risk factors and bioavailability of drugs, but whether these changes are induced by calorie restriction, the weight loss or surgery ...
    • Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity – a non-randomized three-armed controlled trial 

      Kvitne, Kine Eide; Robertsen, Ida; Skovlund, Eva; Christensen, Hege Staaland; Krogstad, Veronica; Wegler, Christine; Angeles, Philip Carlo Soriano; Wollmann, Birgit Malene Tovik; Hole, Kristine; Sandbu, Rune; Artursson, Per; Karlsson, Cecilia; Andersson, Shalini; Andersson, Tommy B.; Hjelmesæth, Jøran; Jansson-Löfmark, Rasmus; Åsberg, Anders (Journal article; Peer reviewed, 2021)
      It remains uncertain whether pharmacokinetic changes following Roux-en-Y gastric bypass (RYGB) can be attributed to surgery-induced gastrointestinal alterations per se and/or the subsequent weight loss. The aim was to ...

      Kontakt oss | Gi tilbakemelding

      Personvernerklæring
      DSpace software copyright © 2002-2019  DuraSpace

      Levert av  Unit
       

       

      Bla i

      Hele arkivetDelarkiv og samlingerUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifter

      Min side

      Logg inn

      Kontakt oss | Gi tilbakemelding

      Personvernerklæring
      DSpace software copyright © 2002-2019  DuraSpace

      Levert av  Unit